Mark Frattini

1 Patent

• US124471712025

  Azacitidine in Combination with Venetoclax, Gilteritinib, Midostaurin or Other Compounds for Treating Leukemia or Myelodysplastic Syndrome

  Celgene Quanticel Research, Inc.

  0 cites